Seth Klarman - Baupost Group

Holding/activity history for  Cascadian Therapeutics Inc. (CASC)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2017   Q3 8,721,079 0.45 $4.09
2017   Q2 8,721,079 0.37 $3.72
2017   Q1 8,721,079 0.43 Add 109.31% 0.22 $4.14
2016   Q4 4,166,666 0.24 $4.31
2016   Q3 4,166,666 0.59 $9.84
2016   Q2 4,166,666 0.32 Buy 0.32 $5.66